BERARDICURTI, ONORINA
 Distribuzione geografica
Continente #
NA - Nord America 1.991
AS - Asia 972
EU - Europa 960
SA - Sud America 121
AF - Africa 20
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.067
Nazione #
US - Stati Uniti d'America 1.950
SG - Singapore 469
RU - Federazione Russa 308
IE - Irlanda 196
CN - Cina 176
VN - Vietnam 112
HK - Hong Kong 107
BR - Brasile 102
IT - Italia 96
DE - Germania 89
SE - Svezia 61
GB - Regno Unito 49
FR - Francia 45
TR - Turchia 38
UA - Ucraina 37
FI - Finlandia 30
CA - Canada 23
IN - India 18
MX - Messico 9
NL - Olanda 9
AR - Argentina 8
PL - Polonia 8
ZA - Sudafrica 7
BD - Bangladesh 6
BE - Belgio 6
CZ - Repubblica Ceca 6
ES - Italia 6
AT - Austria 5
JP - Giappone 5
AE - Emirati Arabi Uniti 4
DO - Repubblica Dominicana 4
IQ - Iraq 4
JO - Giordania 4
LB - Libano 4
SN - Senegal 4
DZ - Algeria 3
ID - Indonesia 3
KR - Corea 3
LT - Lituania 3
PH - Filippine 3
PY - Paraguay 3
VE - Venezuela 3
AZ - Azerbaigian 2
EC - Ecuador 2
HR - Croazia 2
KW - Kuwait 2
NP - Nepal 2
PK - Pakistan 2
SA - Arabia Saudita 2
TN - Tunisia 2
UZ - Uzbekistan 2
AL - Albania 1
AU - Australia 1
BB - Barbados 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CL - Cile 1
CO - Colombia 1
CY - Cipro 1
DK - Danimarca 1
EG - Egitto 1
ET - Etiopia 1
EU - Europa 1
HN - Honduras 1
JM - Giamaica 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MA - Marocco 1
MY - Malesia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
RO - Romania 1
Totale 4.067
Città #
Dallas 325
Chandler 285
Singapore 270
Dublin 196
San Jose 186
Ashburn 166
Jacksonville 157
Hong Kong 106
Santa Clara 80
New York 60
Boardman 59
The Dalles 50
Moscow 42
Ho Chi Minh City 34
L'aquila 30
Los Angeles 30
Beijing 29
Lawrence 28
Princeton 28
Wilmington 26
Izmir 21
Nanjing 21
Hanoi 19
Munich 19
Council Bluffs 18
L’Aquila 16
Lauterbourg 15
San Mateo 15
Hefei 14
Orem 14
Helsinki 13
São Paulo 12
Ann Arbor 11
Dearborn 10
Des Moines 10
Falkenstein 10
Montreal 10
Shanghai 10
Woodbridge 10
Columbus 9
Kitzingen 9
Rome 9
Seattle 9
Stockholm 9
Washington 9
Assago 8
Mountain View 8
Chicago 7
Frankfurt am Main 7
Milan 7
Warsaw 7
Brno 6
Brussels 6
Dong Ket 6
Johannesburg 6
London 6
Nanchang 6
Brooklyn 5
Chennai 5
Da Nang 5
Houston 5
Lappeenranta 5
Manchester 5
Ningbo 5
Paris 5
Poplar 5
Shenyang 5
Tokyo 5
Amman 4
Amsterdam 4
Brasília 4
Dakar 4
Denver 4
Hangzhou 4
Jiaxing 4
Mexico City 4
Nuremberg 4
Pune 4
Vienna 4
Ankara 3
Belo Horizonte 3
Boston 3
Bremen 3
Düsseldorf 3
Edinburgh 3
Grafing 3
Haiphong 3
Hebei 3
Hải Dương 3
Kunming 3
Norwalk 3
Phoenix 3
Rio de Janeiro 3
San Francisco 3
Seoul 3
São José dos Campos 3
Turku 3
Verona 3
Abu Dhabi 2
Andradas 2
Totale 2.749
Nome #
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 175
Unenhanced Cardiac Magnetic Resonance may improve detection and prognostication of an occult heart involvement in asymptomatic patients with systemic sclerosis 170
Evaluating the multivisceral involvement on adult-onset Still’s disease to retrieve imaging-based differences in patients with and without macrophage activation syndrome: results from a single-centre observational study 154
H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome 151
The emerging role of IL-1 inhibition in patients affected by rheumatoid arthritis and diabetes 147
The CD68+/H-ferritin+ cells colonize the lymph nodes of the patients with adult onset Still's disease and are associated with increased extracellular level of H-ferritin in the same tissue: Correlation with disease severity and implication for pathogenesis 138
Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations 136
Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1β via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a possible implication for therapeutic decision in these patients. 135
Clinical features and prognosis of COVID-19 in people with spinal cord injury: a case–control study 131
Mesenchymal stromal cells and rheumatic diseases: new tools from pathogenesis to regenerative therapies. 127
Increased level of H-ferritin and its imbalance with L-ferritin, in bone marrow and liver of patients with adult onset Still's disease, developing macrophage activation syndrome, correlate with the severity of the disease. 122
Dissecting the clinical heterogeneity of adult-onset Still's disease, results from a multi-dimensional characterisation and stratification 122
Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension 121
Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6 120
Severe COVID-19 and related hyperferritinaemia: more than an innocent bystander? 115
The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-β and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist. 115
Derivation and validation of four patient clusters in Still’s disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry 114
Impaired Endothelium-Mesenchymal Stem Cells Cross-talk in Systemic Sclerosis: a Link Between Vascular and Fibrotic Features. 114
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 112
Parenchymal lung disease in adult onset Still's disease: An emergent marker of disease severity - Characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patients 112
IL-1 inhibition improves insulin resistance and adipokines in rheumatoid arthritis patients with comorbid type 2 diabetes: An observational study 108
Myofibroblast Cells Expression of CD248 May Contribute to Exacerbate Microvascular Damage during Systemic Sclerosis 107
Severe COVID-19, Another Piece in the Puzzle of the Hyperferritinemic Syndrome. An Immunomodulatory Perspective to Alleviate the Storm. 107
The assessment of atlantoaxial joint involvement in patients with rheumatoid arthritis, results from an observational "real-life" study 106
The Role of IL-1β in the Bone Loss during Rheumatic Diseases 105
Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study. 105
Is minor salivary gland biopsy more than a diagnostic tool in primary Sjo¨gren׳s syndrome? Association between clinical, histopathological, and molecular features: A retrospective study 104
Still's disease continuum from childhood to elderly: data from the international AIDA Network Still's disease registry 103
Glucocorticoids in Rheumatoid Arthritis: The Silent Companion in the Therapeutic Strategy 101
The Systemic Score May Identify Life‐Threatening Evolution in Still Disease: Data from the GIRRCS AOSD‐Study Group and the AIDA Network Still Disease Registry 98
The wide spectrum of Kawasaki-like disease associated with SARS-CoV-2 infection 97
The specialized pro-resolving lipid mediator Protectin D1 affects macrophages differentiation and activity in Adult-onset Still’s disease and COVID-19, two hyperinflammatory diseases sharing similar transcriptomic profiles 94
Association between Patient Acceptable Symptom State and disease activity in psoriatic arthritis is disrupted by confounders, including comorbid fibromyalgia 86
Association between clinical, histopathological and molecular features in primary Sjogren's Syndrome: a retrospective study 86
THU0582 Prognostic Factors of Macrophage Activation Syndrome in Adults: Analysis of 40 Cases in 2 Tertiary Referral Centers 83
Specialized pro-resolving mediators and autoimmunity: Recent insights and future perspectives 33
Totale 4.154
Categoria #
all - tutte 17.249
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.249


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202157 0 0 0 0 0 0 0 0 0 8 38 11
2021/2022163 5 5 24 9 2 4 0 5 11 22 15 61
2022/2023666 57 54 17 96 37 73 0 39 249 3 27 14
2023/2024214 30 4 14 11 19 66 1 15 3 5 16 30
2024/2025810 33 13 51 52 105 66 97 58 163 63 55 54
2025/20261.726 112 172 235 195 181 116 261 45 143 266 0 0
Totale 4.154